1 |
中华医学会呼吸病学会分会间质性肺疾病学组. 特发性肺纤维化诊断和治疗中国专家共识[J]. 中华结核和呼吸杂志,2016, 39(6): 427-432.
|
2 |
王在强,傅恩清. 调节性T细胞在肺纤维化中作用的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 237-240.
|
3 |
陈宇平,朱 毅. 特发性肺纤维化与胃食道返流研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(4): 551-554.
|
4 |
崔付生. 抗肺纤合方剂联合西医常规治疗肺间质纤维化的疗效及对炎症因子水平、肺部损伤情况和肺功能的影响[J]. 中医研究,2022, 35(6): 37-42.
|
5 |
池 菲,张 新,王晓静,等. 慢性阻塞性肺疾病患者并发肺间质纤维化的血清学预测指标研究[J]. 中国医药,2021, 16(10): 1534-1538.
|
6 |
中华医学会呼吸病分会. 特发性肺纤维化急性加重诊断和治疗中国专家共识[C]//中华医学杂志,2019, 99(26): 2014-2023.
|
7 |
中华医学会呼吸病学分会. 成人经鼻高流量湿化氧疗临床规范应用专家共识[C]//中华结核呼吸杂志,2019, 42(2): 83-91.
|
8 |
胡晨阳,翟成凯,翟 飞,等. 大剂量N-乙酰半胱氨酸辅助治疗慢性阻塞性肺疾病并肺间质纤维化的效果及其对肺功能、炎性因子指标及血管内皮生长因子的影响[J]. 中国医学工程,2021, 29(7): 126-128.
|
9 |
黄 慧,徐作军. 国际特发性肺纤维化指南及进展性肺纤维化临床诊疗指南摘译[J]. 中华结核和呼吸杂志,2022, 45(7): 721-724.
|
10 |
Horio Y, Takihara T, Niimi K, et al. High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series[J]. Respir Investig, 2016, 54(2): 125-129.
|
11 |
Bernardinello N, Grisostomi G, Cocconcelli E, et al. The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF)[J]. Respir Med, 2022, 191: 106686.
|
12 |
Nambiar S, Clynick B, How BS, et al. There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF)[J]. Respir Res, 2021, 22(1): 105.
|
13 |
Legué S, Marchand AS, Plantier L, et al. ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution (TOUPIE): research protocol of a multicentric prospective study[J]. BMJ open, 2021, 11(3): e039078.
|
14 |
Claire MN, Veronica D, Matthew M, et al. Validity, responsiveness and minimum clinically important difference of the incremental shuttle walk in idiopathic pulmonary fibrosis: a prospective study[J]. Thorax, 2017, thoraxjnl-2017-210589.
|
15 |
胡朝阳,张小红,常 瑞,等. 汉防己甲素片联合吡非尼酮治疗肺间质纤维化的临床研究[J]. 现代药物与临床,2020, 35(4): 739-743.
|
16 |
王 瑞,王建华,柴海强. 特发性肺间质纤维化MSCT影像学征象及与肺功能指标的相关性研究[J]. 中国CT和MRI杂志,2020, 18(3): 62-65.
|
17 |
吴玉枝,武爱萍. 大剂量N-乙酰半胱氨酸对慢性阻塞性肺疾病合并肺间质纤维化患者肺功能、血清指标及血气指标的影响[J]. 中国基层医药,2019, 26(21): 2569-2573.
|
18 |
Halime Y, Pinar Y, Ender C. Investigation of telomere related gene mutations in idiopathic pulmonary fibrosis[J]. Mol Biol Rep, 2020, 47(10): 7851-7860.
|
19 |
Wu WJ, Wu XH, Qiu LX. Quercetin isnfluences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis[J]. Naunyn Schmiedebergs Arch Pharmacol, 2023, doi: 10.1007/s00210-023-02913-8.
|
20 |
Üzer F, Akanlar S, Çilli A, et al. Real-life data in the treatment and follow-up of idiopathic pulmonary fibrosis: A single-center study[J]. Tuberk Toraks, 2023, 71(4): 347-355.
|